CIAS
REGN icon

CBIZ Investment Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History

CBIZ Investment Advisory Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.86K Hold
5
– – ﹤0.01% 256
2026
Q1 		$3.86K Sell
5
-12
-71% -$9.19K ﹤0.01% 256
2025
Q4 		$13.1K Hold
17
– – ﹤0.01% 337
2025
Q3 		$9.56K Sell
17
-34
-67% -$19.2K ﹤0.01% 348
2025
Q2 		$26.8K Buy
51
+50
+5,000% +$27.9K ﹤0.01% 216
2025
Q1 		$634 Sell
1
-1
-50% -$688 ﹤0.01% 533
2024
Q4 		$1.43K Hold
2
– – ﹤0.01% 423
2024
Q3 		$2.1K Hold
2
– – ﹤0.01% 342
2024
Q2 		$2.1K Hold
2
– – ﹤0.01% 332
2024
Q1 		$1.93K Buy
+2
New +$1.9K ﹤0.01% 309

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

CBIZ Investment Advisory Services's REGN Position: Q2 2026 in Review

CBIZ Investment Advisory Services held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 5 shares worth $3.86K. The position accounts for ﹤0.01% of the portfolio, ranked #256.

CBIZ Investment Advisory Services first reported a position in REGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $26.8K in Q2 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • CBIZ Investment Advisory Services held 5 shares of Regeneron Pharmaceuticals worth $3.86K as of Q2 2026.
  • CBIZ Investment Advisory Services left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of CBIZ Investment Advisory Services's portfolio in Q2 2026, its #256 holding.
  • CBIZ Investment Advisory Services first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • CBIZ Investment Advisory Services's Regeneron Pharmaceuticals position peaked at $26.8K in Q2 2025.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q2 2026, filed 13 Aug 2026.